Road map for fibrolamellar carcinoma: progress and goals of a diversified approach

References

• CheungJGinterCCassidyMStructural insights into misregulation of protein kinase A in human tumorsProc Natl Acad Sci U S A201511251374137925605907
   PubMed Web of Science ®Google Scholar
• OikawaTWauthierEDinhTAModel of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cellsNat Commun201561807026437858
   PubMed Web of Science ®Google Scholar
• EngelholmLHRiazASerraDCRISPR/Cas9 engineering of adult mouse liver demonstrates that the dnajb1-prkaca gene fusion is sufficient to induce tumors resembling fibrolamellar hepatocellular carcinomaGastroenterology201715361662167328923495
   PubMed Web of Science ®Google Scholar
• KastenhuberERLalazarGHoulihanSLDNAJB1-PRKACA fusion kinase interacts with β-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinomaProc Natl Acad Sci U S A201711450130761308429162699
   PubMed Web of Science ®Google Scholar
• DinhTAVitucciECWauthierEComprehensive analysis of the Cancer genome atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinomaSci Rep2017714465328304380
   PubMed Web of Science ®Google Scholar
• ZehirABenayedRShahRHMutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patientsNat Med201723670371328481359
   PubMed Web of Science ®Google Scholar
• SmithFDEsseltineJLNygrenPJLocal protein kinase a action proceeds through intact holoenzymesScience201735663441288129328642438
   PubMed Web of Science ®Google Scholar
• CraigJRPetersRLEdmondsonHAOmataMFibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive Clinico-pathologic featuresCancer19804623723796248194
   PubMed Web of Science ®Google Scholar
• KasebAOShamaMSahinIHPrognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinomaOncology201385419720324051705
   PubMed Web of Science ®Google Scholar
• GrahamRPJinLKnutsonDLDNAJB1-PRKACA is specific for fibrolamellar carcinomaMod Pathol201528682282925698061
   PubMed Web of Science ®Google Scholar
• AngCSKelleyRKChotiMAClinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma ConsortiumGastrointest Cancer Res2013613923505572
   PubMedGoogle Scholar
• LimIIFarberBALaquagliaMPAdvances in fibrolamellar hepatocellular carcinoma: a reviewEur J Pediatr Surg201424646146625486412
   PubMed Web of Science ®Google Scholar
• GhassanKAbou-AlfaRJMCosgroveDRandomized phase II study of everolimus (E), leuprolide + letrozole (ll), and E + ll (ELL) in patients (PTS) with unresectable fibrolamellar carcinoma (FLC)J Clin Oncol201533Suppl 15e15149
   Web of Science ®Google Scholar
• HoneymanJNSimonEPRobineNDetection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinomaScience201434361741010101424578576
   PubMed Web of Science ®Google Scholar
• XuLHazardFKZmoosAFGenomic analysis of fibrolamellar hepatocellular carcinomaHum Mol Genet2015241506325122662
   PubMed Web of Science ®Google Scholar
• CornellaHAlsinetCSayolsSUnique genomic profile of fibrolamellar hepatocellular carcinomaGastroenterology2015148480681825557953
   PubMed Web of Science ®Google Scholar
• GröbnerSNWorstBCWeischenfeldtJThe landscape of genomic alterations across childhood cancersNature2018555769632132729489754
   PubMed Web of Science ®Google Scholar
• MessierTLBoydJRGordonJASteinJLLianJBSteinGSOncofetal epigenetic bivalency in breast cancer cells: H3K4 and H3K27 tri-methylation as a biomarker for phenotypic plasticityJ Cell Physiol2016231112474248126916849
   PubMed Web of Science ®Google Scholar
• OhSHSwiderska-SynMJewellMLPremontRTDiehlAMLiver regeneration requires Yap1-TGFβ-dependent epithelial-mesenchymal transition in hepatocytesJ Hepatol201869235936729758331
   PubMed Web of Science ®Google Scholar
• LarkinJChiarion-SileniVGonzalezRCombined nivolumab and ipilimumab or monotherapy in untreated melanomaN Engl J Med20153731233426027431
   PubMed Web of Science ®Google Scholar
• BrahmerJReckampKLBaasPNivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancerN Engl J Med2015373212313526028407
   PubMed Web of Science ®Google Scholar
• OkadaHKohanbashGZhuXImmunotherapeutic approaches for gliomaCrit Rev Immunol200929114219348609
   PubMed Web of Science ®Google Scholar
• TsengDVolkmerJPWillinghamSBAnti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell responseProc Natl Acad Sci U S A201311027111031110823690610
   PubMed Web of Science ®Google Scholar
• PyonteckSMAkkariLSchuhmacherAJCSF-1R inhibition alters macrophage polarization and blocks glioma progressionNat Med201319101264127224056773
   PubMed Web of Science ®Google Scholar
• GeeMHHanALofgrenSMAntigen identification for orphan T cell receptors expressed on tumor-infiltrating lymphocytesCell2018172354956329275860
   PubMed Web of Science ®Google Scholar
• Ben-DavidUHaGTsengYYPatient-derived xenografts undergo mouse-specific tumor evolutionNat Genet201749111567157528991255
   PubMed Web of Science ®Google Scholar
• HeLLiYLiYEnhancing the precision of genetic lineage tracing using dual recombinasesNat Med201723121488149829131159
   PubMed Web of Science ®Google Scholar
• BroutierLAndersson-RolfAHindleyCJCulture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulationNat Protoc20161191724174327560176
   PubMed Web of Science ®Google Scholar
• GoesslingWSadlerKCZebrafish: an important tool for liver disease researchGastroenterology201514961361137726319012
   PubMed Web of Science ®Google Scholar
• AsaokaYTeraiSSakaidaINishinaHThe expanding role of fish models in understanding non-alcoholic fatty liver diseaseDis Model Mech20136490591423720231
   PubMed Web of Science ®Google Scholar
• DarACDasTKShokatKMCaganRLChemical genetic discovery of targets and anti-targets for cancer polypharmacologyNature20124867401808422678283
   PubMed Web of Science ®Google Scholar
• EvasonKJFranciscoMTJuricVIdentification of chemical inhibitors of β-Catenin-Driven liver tumorigenesis in zebrafishPLoS Genet2015117e100530526134322
   PubMed Web of Science ®Google Scholar
• FiorRPóvoaVMendesRVSingle-cell functional and chemo-sensitive profiling of combinatorial colorectal therapy in zebrafish xenograftsProc Natl Acad Sci U S A201711439E8234E824328835536
   PubMed Web of Science ®Google Scholar
• RiggleKMRiehleKJKenersonHLEnhanced cAMP-stimulated protein kinase a activity in human fibrolamellar hepatocellular carcinomaPediatr Res201680111011827027723
   PubMed Web of Science ®Google Scholar
• KirschnerLSYinZJonesGNMahoneyEMouse models of altered protein kinase a signalingEndocr Relat Cancer200916377379319470615
   PubMed Web of Science ®Google Scholar
• TurnhamREScottJDProtein kinase a catalytic subunit isoform PRKACA; history, function and physiologyGene2016577210110826687711
   PubMed Web of Science ®Google Scholar
• NygrenPJScottJDTherapeutic strategies for anchored kinases and phosphatases: exploiting short linear motifs and intrinsic disorderFront Pharmacol20156e100149215826283967
   PubMed Web of Science ®Google Scholar
• The Cancer Genome Atlas Research NetworkIntegrated genomic characterization of pancreatic ductal adenocarcinomaCancer Cell2017322185203.e1328810144
   PubMed Web of Science ®Google Scholar
• BeuschleinFFassnachtMAssiéGConstitutive activation of PKA catalytic subunit in adrenal Cushing’s syndromeN Engl J Med2014370111019102824571724
   PubMed Web of Science ®Google Scholar
• GrahamRPLacknerCTerraccianoLFibrolamellar carcinoma in the Carney complex: PRKAR1A loss instead of the classic DNAJB1-PRKACA fusionHepatology20186841441144729222914
   PubMed Web of Science ®Google Scholar
• MoodySESchinzelACSinghSPRKACA mediates resistance to HER2-targeted therapy in breast cancer cells and restores anti-apoptotic signalingOncogene201534162061207124909179
   PubMed Web of Science ®Google Scholar
• PatraKCKatoYMizukamiYMutant Gnas drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolismNat Cell Biol201820781182229941929
   PubMed Web of Science ®Google Scholar
• SkålheggBSHuangYSuTIdzerdaRLMcknightGSBurtonKAMutation of the Calpha subunit of PKA leads to growth retardation and sperm dysfunctionMol Endocrinol200216363063911875122
   PubMedGoogle Scholar
• LochnerAMoolmanJAThe many faces of H89: a reviewCardiovasc Drug Rev2006243–426127417214602
   PubMed Web of Science ®Google Scholar
• DrukerBJTalpazMRestaDJEfficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemiaN Engl J Med2001344141031103711287972
   PubMed Web of Science ®Google Scholar
• de ThéHChenZAcute promyelocytic leukaemia: novel insights into the mechanisms of cureNat Rev Cancer2010101177578320966922
   PubMed Web of Science ®Google Scholar
• PagliariniRShaoWSellersWROncogene addiction: pathways of therapeutic response, resistance, and road maps toward a cureEMBO Rep201516328029625680965
   PubMed Web of Science ®Google Scholar
• AjmeraVPeritoERBassNMNovel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver diseaseHepatology2017651657727532276
   PubMed Web of Science ®Google Scholar
• ParadinasFJMeliaWMWilkinsonMLHigh serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinomaBr Med J198228563458408426288165
   PubMed Web of Science ®Google Scholar
• KanaiTTakabayashiTKawanoYKuramochiSMiyazawaNA case of postoperative recurrence of fibrolamellar hepatocellular carcinoma with increased vitamin B12 binding capacity in a young Japanese femaleJpn J Clin Oncol200434634635115333688
   PubMed Web of Science ®Google Scholar
• NakaoAVirjiAIwakiYCarrBIwatsukiSStarzlEAbnormal prothrombin (des-gamma-carboxy prothrombin) in hepatocellular carcinomaHepatogastroenterology19913854504531722483
   PubMed Web of Science ®Google Scholar
• CollierNABloomSRHodgsonHJFWeinbrenKLeeYCBlumgartLHNeurotensin secretion by fibrolamellar carcinoma of the liverThe Lancet19843238376538540
   Google Scholar
• GaneshanDSzklarukJKundraVImaging features of fibrolamellar hepatocellular carcinomaAJR Am J Roentgenol2014202354455224555590
   PubMed Web of Science ®Google Scholar
• LiuSWah ChanKTongJWangYWangBQiaoLPET-CT scan is a valuable modality in the diagnosis of fibrolamellar hepatocellular carcinoma: a case report and a summary of recent literatureQJM2011104647748321493692
   PubMed Web of Science ®Google Scholar
• ManchadoEWeissmuellerSMorrisJPA combinatorial strategy for treating KRAS-mutant lung cancerNature2016534760964765127338794
   PubMed Web of Science ®Google Scholar
• ChandarlapatySSawaiAScaltritiMAkt inhibition relieves feedback suppression of receptor tyrosine kinase expression and activityCancer Cell2011191587121215704
   PubMed Web of Science ®Google Scholar
• GorreMEMohammedMEllwoodKClinical resistance to STI-571 cancer therapy caused by Bcr-Abl gene mutation or amplificationScience2001293553187688011423618
   PubMed Web of Science ®Google Scholar
• GlickmanMSSawyersCLConverting cancer therapies into cures: lessons from infectious diseasesCell201214861089109822424221
   PubMed Web of Science ®Google Scholar